Cookies on this site

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.

The humanoid robotic bioreactor at NDORMS © David Fisher

For more than 20 years, it has been possible to grow and stretch tissue cells outside of the human body using dynamic bioreactors; systems that control the conditions necessary for maintaining and stimulating living cells and tissues, while involving external mechanical stresses. However, it has still not been possible to produce tendon tissues of high enough quality to work successfully in human grafts.

An important limitation is in the method of mechanically stimulating the cells as Pierre-Alexis Mouthuy, lead author of the study explained. "We're far away from fully functional tendon tissue grafts, and this is partially because we're not providing the complexity of mechanical stresses that cells would experience in a human shoulder," he said. "Existing evidence suggests that delivering advanced physiologically-relevant mechanical cues, or realistic movement of the shoulder up, down, back and forward, with the cells being pushed, pulled, compressed and stretched, is important to mature the tissue properly."

Most current bioreactor systems are only able to deliver unidirectional stretching to the cells, so Pierre and the team from NDORMS looked to real-size musculoskeletal (MSK) humanoid robots as a possible solution to provide physiological stresses, i.e. multidirectional ones. MSK humanoid robots aim to replicate the human musculoskeletal system by mimicking the structure and mechanics of muscles, tendons and bones.

The flexible bioreactor chamber is subjected to repeated abduction-adduction exercises. The flexible bioreactor chamber is subjected to repeated abduction-adduction exercises.

Their paper, published in Communications Engineering, explains how they firstly designed a flexible bioreactor chamber. Inside the chamber, cells were grown on stretchy synthetic scaffolds while being perfused with culture medium (providing them with oxygen and nutrients). On a daily basis, the chambers were positioned on the robotic arm and were subjected to repeated abduction-adduction exercises to replicate some of the forces and movements that they would undergo in a real tendon.

Pierre and his team hope that, in the future, lab grown tendon grafts can be used to improve repair outcomes in patients. "Now that we've demonstrated the feasibility of a humanoid bioreactor approach, we can explore the possibilities of this new platform and see if providing these more physiologically relevant mechanical stresses can really help to improve the quality of engineered tendon grafts."

See the robotic bioreactor in action in this Nature video.

Similar stories

New platform improves accuracy of molecular counting in RNA-sequencing

Researchers at NDORMS have developed a new computational platform to improve the accuracy of molecular counting in RNA-sequencing, helping scientists generate more reliable data for genetic research.

Professor Menna Clatworthy to join the Kennedy Institute at NDORMS

Professor Menna Clatworthy, recently announced as the new Regius Professor of Medicine at the University of Oxford, will join the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) as a Principal Investigator at the Kennedy Institute of Rheumatology with effect from March 2027. Professor Clatworthy will also join the Nuffield Department of Surgical Sciences highlighting the breadth and relevance of her research to multiple medical departments in Oxford.

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.